Therapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases

Noemi Rotllan,Mercedes Camacho,Mireia Tondo,Elena M G Diarte-Añazco,Marina Canyelles,Karen Alejandra Méndez-Lara,Sonia Benitez,Núria Alonso,Didac Mauricio,Joan Carles Escolà-Gil,Francisco Blanco-Vaca,Josep Julve
DOI: https://doi.org/10.3390/antiox10121939
2021-12-03
Abstract:Cardiovascular diseases are the leading cause of death worldwide. Aging and/or metabolic stress directly impact the cardiovascular system. Over the last few years, the contributions of altered nicotinamide adenine dinucleotide (NAD+) metabolism to aging and other pathological conditions closely related to cardiovascular diseases have been intensively investigated. NAD+ bioavailability decreases with age and cardiometabolic conditions in several mammalian tissues. Compelling data suggest that declining tissue NAD+ is commonly related to mitochondrial dysfunction and might be considered as a therapeutic target. Thus, NAD+ replenishment by either genetic or natural dietary NAD+-increasing strategies has been recently demonstrated to be effective for improving the pathophysiology of cardiac and vascular health in different experimental models, as well as human health, to a lesser extent. Here, we review and discuss recent experimental evidence illustrating that increasing NAD+ bioavailability, particularly by the use of natural NAD+ precursors, may offer hope for new therapeutic strategies to prevent and treat cardiovascular diseases.
What problem does this paper attempt to address?